Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy

[1] Weng Z(2016)Prognostic value of LGE-CMR in HCM: a meta-analysis JACC Cardiovasc Imaging 9 1392-1402

[2] Yao J(2013)T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy Circ Cardiovasc Imaging 6 415-422

[3] Chan RH(2014)Mitochondrial DNA variations associated with hypertrophic cardiomyopathy Mitochondrion 16 65-72

[4] He J(2017)Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes Eur Heart J. 363 552-563

[5] Yang X(2010)Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 15 1108-1116

[6] Zhou Y(2014)A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype Eur Heart J Cardiovasc Imaging 74 2333-2345

[7] Ho CY(2019)Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry J Am Coll Cardiol 9 1671-1398

[8] Abbasi SA(2020)Genotype-related clinical characteristics and myocardial fibrosis and their association with prognosis in hypertrophic cardiomyopathy J Clin Med. 138 1387-3033

[9] Neilan TG(2018)Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe) Circulation 33 3023-56

[10] Shah RV(2012)Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management Eur Heart J 53 48-645

[1] Weng Z(2016)Prognostic value of LGE-CMR in HCM: a meta-analysis JACC Cardiovasc Imaging 9 1392-1402

[2] Yao J(2013)T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy Circ Cardiovasc Imaging 6 415-422

[3] Chan RH(2014)Mitochondrial DNA variations associated with hypertrophic cardiomyopathy Mitochondrion 16 65-72

[4] He J(2017)Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes Eur Heart J. 363 552-563

[5] Yang X(2010)Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 15 1108-1116

[6] Zhou Y(2014)A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype Eur Heart J Cardiovasc Imaging 74 2333-2345

[7] Ho CY(2019)Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry J Am Coll Cardiol 9 1671-1398

[8] Abbasi SA(2020)Genotype-related clinical characteristics and myocardial fibrosis and their association with prognosis in hypertrophic cardiomyopathy J Clin Med. 138 1387-3033

[9] Neilan TG(2018)Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe) Circulation 33 3023-56

[10] Shah RV(2012)Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management Eur Heart J 53 48-645